IMCD, a global leader in specialty chemicals and ingredients distribution, reported a steady performance for the first quarter of 2026, with an EBITA of €130 million. The company highlighted resilience amid ongoing global economic uncertainty, including trade tensions and fluctuating demand.
According to the company's official release on May 1, 2026, revenue for Q1 2026 was €1.2 billion, reflecting a slight increase compared to the same period last year. The EBITA margin remained stable at 10.8%, supported by cost control measures and a diversified portfolio.
CEO Piet van der Slikke commented, 'Our Q1 results demonstrate the strength of our business model and the dedication of our teams. We continue to navigate a complex macroeconomic environment with discipline and focus on long-term growth.'
The company's performance was driven by strong demand in the life sciences and industrial sectors, partially offset by weakness in certain construction-related markets. IMCD reaffirmed its full-year 2026 outlook, expecting moderate growth.
